IMPACT THERAP-B

7630
9.3252.30% ( +0.210 )
Delay Closed: Nov 16, 16:08:11

Valuation

Current ValuationThe current P/E ratio is -8.87, above the reasonable range, cheaper than 7.35% of the time in the past 1 years, and the industry ranks 49/78, the industry Median -4.86.

-8.87xP/E
Stock priceHK$9.33Earnings per shareHK$-1.05

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0152304456608

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-54.18x71.81%HK$60.33B
09688HKZAI LAB
-15.51x17.69%HK$24.13B
01877HKJUNSHI BIO
-31.64x83.59%HK$14.54B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
07666HKMETIS TECHBIO-P
-24.60x96.67%HK$10.01B
06855HKASCENTAGE
-5.79x19.11%HK$9.79B
01952HKEVEREST MED
-147.04x326.79%HK$9.13B
09606HKDUALITYBIO-B
-5.35x85.35%HK$8.86B
02616HKCSTONE PHARMA-B
-17.06x1.09%HK$8.23B
02493HKMABWELL-B
-6.50x--HK$7.95B
02595HKGENFLEET-B
-4.86x66.07%HK$7.36B
06938HKRIBOLIFE-B
-34.82x29.56%HK$6.80B
09887HKLEADS BIOLABS-B
-21.52x3.57%HK$6.62B
02335HKMICOT PHARMA-B
-15.65x37.52%HK$6.57B
02171HKCARSGEN-B
-58.05x52.33%HK$5.96B
09966HKALPHAMAB-B
-26.96x--HK$5.46B
00775HKCKLIFE SCIENCES
-77.99x--HK$5.05B
02256HKABBISKO-B
-8.56x814.43%HK$4.60B
01672HKASCLETIS-B
-6.60x78.53%HK$4.50B
01779HKLONGBIO-B
-17.26x--HK$4.30B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.